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Abstract
The homeobox gene (HOXA13) codes for a transcription factor protein that binds to AT-rich DNA sequences and controls
expression of genes during embryonic morphogenesis. Here we present the NMR structure of HOXA13 homeodomain
(A13DBD) bound to an 11-mer DNA duplex. A13DBD forms a dimer that binds to DNA with a dissociation constant of 7.5
nM. The A13DBD/DNA complex has a molar mass of 35 kDa consistent with two molecules of DNA bound at both ends of
the A13DBD dimer. A13DBD contains an N-terminal arm (residues 324 – 329) that binds in the DNA minor groove, and a C-
terminal helix (residues 362 – 382) that contacts the ATAA nucleotide sequence in the major groove. The N370 side-chain
forms hydrogen bonds with the purine base of A5* (base paired with T5). Side-chain methyl groups of V373 form
hydrophobic contacts with the pyrimidine methyl groups of T5, T6* and T7*, responsible for recognition of TAA in the DNA
core. I366 makes similar methyl contacts with T3* and T4*. Mutants (I366A, N370A and V373G) all have decreased DNA
binding and transcriptional activity. Exposed protein residues (R337, K343, and F344) make intermolecular contacts at the
protein dimer interface. The mutation F344A weakens protein dimerization and lowers transcriptional activity by 76%. We
conclude that the non-conserved residue, V373 is critical for structurally recognizing TAA in the major groove, and that
HOXA13 dimerization is required to activate transcription of target genes.
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Introduction
Homeobox (Hox) genes encode a conserved family of
transcription factor proteins that are critically important in
vertebrate development [1]. In humans, the Hox genes are
distributed into four linkage groups (HOXA, B, C, D) comprising
39 genes located on chromosomes 7, 17, 12, and 2 (Fig. 1).
Recently, mutations in HOXA13 have been associated with
Hand-Foot-Genital-(HFGS) and Guttmacher syndromes (GS),
autosomal dominant disorders that profoundly affect limb and
genitourinary development causing defects in the digits, carpal/
tarsal bones, uterus, bladder, Mullerian ducts, and the external
genitalia [2,3,4]. In mice, loss of function studies have confirmed a
conserved role for HOXA13 in limb and genitourinary develop-
ment and also identified a novel function for HOXA13 in the
developing murine placenta, where it regulates the expression of
Tie2 and Foxf1a to facilitate the formation of the placental vascular
labyrinth [5,6,7].
While it is well-established that HOXA13 is essential for the
formation of many different tissues, it is less clear how HOXA13
mediates the tissue-specific expression of its target genes. To
address this question, a SELEX approach was used to identify a
consensus sequence of 59-AAATAAAA-39 preferred by HOXA13
[8]. The core sequence in the major groove (59-ATAA-39)i s
somewhat different from the corresponding sequence (59-ATCA-
39) recognized by most other HOX proteins [9]. Another unique
feature of HOXA13 is that it binds tightly to specific DNA targets
(Kd=3.7 nM) without the aid of any cofactors [8]. This is in stark
contrast to other known HOX proteins that require MEIS-class
[10,11] and/or PBC-class cofactors [12,13] to enable high affinity
DNA binding. An atomic-resolution structure of HOXA13 bound
to duplex DNA is therefore needed to elucidate its sequence-
specific DNA binding and provide a structural basis for
understanding how mutations in HOXA13 cause HFGS and GS.
Here we report the NMR structure of the murine HOXA13
DNA binding domain (residues 314–386, called A13DBD) bound
to an 11-residue DNA duplex. Interestingly, the A13DBD forms a
dimer in solution bound to two molecules of duplex DNA, forming
a 2:2 complex called, (A13DBD)2-(DNA)2. The structure contains
a positively charged N-terminal arm that forms electrostatic
contacts in the minor groove of DNA. Exposed residues on the C-
terminal helix make sequence-specific contacts in the major
groove. N370 forms critical hydrogen-bonds with the purine base
of A5* (astericks indicates base paired with T5, see Fig. 1B for
duplex base pair numbering). V373 makes a cooperative network
of hydrophobic contacts with pyrimidine methyl groups in the
major groove and thus explains the specific recognition of 59-
TAA-39 in the core sequence. Exposed protein residues, R337 and
F344 contact each other at the protein dimer interface. Mutating
F344 weakens protein dimerization and diminishes the transcrip-
tional activation function. We propose that homodimerization of
HOXA13 might promote multi-valent DNA contacts to help bend
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23069the DNA template and recruit the transcriptional machinery
needed to regulate target gene expression.
Results
NMR-derived Structure of A13DBD
The
1H-
15N HSQC NMR spectrum of A13DBD [14] exhibited
the expected number of amide resonances with good chemical shift
dispersion and uniform intensities, indicative of a folded protein
[14]. Sequence specific NMR assignments of A13DBD were
analyzed and described previously (BMRB no. 16252). The
assigned NMR resonances represent main chain and side chain
amide groups that serve as fingerprints of overall conformation.
Three-dimensional protein structures derived from the NMR
assignments were calculated on the basis of NOE data, chemical
shift analysis, and
3JNHa spin-spin coupling constants (see Methods).
The final NMR-derived structures of A13DBD are illustrated in
Fig.2 (atomic coordinateshave been depositedintheRCSB Protein
Databank, accession no. 2l7z). Table 1 summarizes the structural
statistics calculated for 15 lowest energy conformers with an RMSD
of 0.4 A ˚ (main chain atoms) and 1.15 A ˚ for all heavy atoms.
The main chain structure of A13DBD adopts a canonical
homeodomain fold with a positively charged N-terminal arm
(residues 321–327) and three a-helices: a1 (residues 329–341), a2
(residues 347–356) and a3 (residues 362–379) shown schematically
in Fig. 1A. The first two helices form an antiparallel helical hairpin
with electrostatic salt bridges between the two helices at E334/
R352 and E338/R350. A long C-terminal helix lays perpendicular
to the hairpin helices. Exposed residues on the C-terminal helix
(I366, N370, V373, K377, K381) correspond to DNA binding
residues in the structures of other homeodomain proteins, Hoxb1
[9], Pdx1 [15], antennapedia [16,17], engrailed [18,19], and
Hoxa9 [20].
A13DBD Binding to 11-mer DNA
An 11-mer oligonucleotide (59-CAAATAAAATC-39) was the
minimal DNA sequence containing the ATAA core [8] that
formed a stable duplex and exhibited high affinity and sequence
specific binding to A13DBD (see Fig. 1B for duplex base pair
numbering). The binding of the 11-mer DNA duplex to A13DBD
was quantitatively measured by isothermal titration calorimetry
(Fig. S7). The ITC isotherm shows that A13DBD binds
exothermically to the duplex (DH=230.1 kcal/mol) with an
apparent dissociation constant of 7.5 nM and stoichiometric
binding ratio of one (Fig. S7). The binding stoichiometry of one
was confirmed by NMR titrations that monitored spectral changes
Figure 1. Primary sequence of HoxA13 and 11-mer duplex DNA. (A) Amino acid sequence alignment of HOXA13 with other homeodomain
proteins: HOXA9, HOXB13, HOXB1 and Pdx1. Residues at the DNA binding interface are highlighted bold and residues at the dimer interface are
colored red. (B) Nucleotide sequence of 11-mer duplex DNA. The sense oligonucleotide strand is numbered from 1 to 11 in the 59 to 39 direction and
the complementary strand is numbered from 1* to 11* in the 39 to 59 direction. The thymine bases that interact with V373 are highlighted bold.
doi:10.1371/journal.pone.0023069.g001
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A13DBD (Fig. S1).
Molar Mass of A13DBD/DNA Complex
The molar mass of the A13DBD/DNA complex in solution was
determined by measuring its molecular diffusion by NMR.
15N
NMR relaxation measurements on the A13DBD/DNA complex
(R2/R1=35.4) indicate an average rotational correlation time of
18-ns at 37uC, consistent with a spherical mass of 3564 kDa
(Figure S2 and Table 2). NMR pulsed-field gradient diffusion
studies [21] determined a translational diffusion coefficient
(D=9610
211 m
2/s) consistent with a molar mass of ,35 kDa.
Lastly, the molar mass of the A13DBD/DNA complex in solution
was determined to be 3565 kDa based on size-exclusion
chromatography (SEC) calibrated using molecular mass standards
and multi-angle light scattering (MALS) analysis (Table 2). The
observed mass at 3564 kDa indicates that a dimer of A13DBD
(,20 kDa) must bind to two DNA duplex molecules (,7 kDa
each), giving an expected total mass of 34 kDa. Two 11-mer DNA
duplex molecules bound to a protein dimer gives a binding
stoichiometry of 2:2, hereafter designated as (A13DBD)2-(DNA)2.
The dimerization of A13DBD determined above is somewhat
inconsistent with previous analytical ultracentrifugation studies
that suggest A13DBD is a protein monomer bound to a single
DNA hairpin [22]. The A13DBD dimerization may have been
disrupted or weakend in the sedimentation studies due to its
binding to a DNA hairpin instead of duplex DNA that was used in
the current study. The SEC mass analysis measured above as a
function of protein concentration indicates a dissociation constant
of A13DBD dimerization to be ,500 nM, suggesting that
(A13DBD)2-(DNA)2 should be quite stable and remain intact
under physiological conditions.
Structure of A13DBD bound to duplex DNA
After characterizing the DNA binding properties above, we next
set out to determine the NMR structure of (A13DBD)2-(DNA)2.
We have previously reported the NMR spectra and assignments of
(A13DBD)2-(DNA)2 [23]. The backbone chemical shifts, residual
dipolar couplings (Fig. S9), and inter-helical NOE patterns
(involving L335, I353 and V364) all demonstrate that the overall
main chain structure of A13DBD in the complex is quite similar to
the structure of the free protein above. Minor structural changes
induced by DNA-binding are observed in the N-terminal arm
(residues 323–329) and the C-terminal helix in the complex
becomes elongated by one helical turn (see Fig. 1A, residues 362–
382).
Figure 2. NMR-derived structures of A13DBD in solution. (A)
Superposition of main chain atoms of 15 lowest energy structures with
RMSD of 0.4 A ˚ (main chain atoms). (B) Ribbon representation of the
energy-minimized average main chain structure. The three a-helices are
highlighted magenta (a1, residues 329–341), cyan (a2, residues 347–
356), and green (a3, residues 362–379).
doi:10.1371/journal.pone.0023069.g002
Table 1. Structure Statistics for NMR-derived Structures of
A13DBD.
NOE restraints (total) 778
intra (i – j=0) 139
medium (1 # i– j#4) 564
long (i – j .4) 75
dihedral angle restraints (w and y)8 6
hydrogen bond restraints in a–helical regions 54
RMSD from ideal geometry: bond length (A ˚) 0.008960.00014
RMSD from ideal geometry: bond angle (deg) 1.9660.0097
Ramachandran plot: most favored region (%) 70.1
Ramachandran plot: allowed region (%) 28.3
Ramachandran plot: disallowed region (%) 1.5
RMSD: a-helical regions (main chain) (A ˚) 0.460.089
RMSD: a-helical regions (non-hydrogen) (A ˚) 1.1560.11
doi:10.1371/journal.pone.0023069.t001
Table 2. Molecular Mass of A13DBD (WT and F344A) bound
to 11-mer DNA Duplex.
Method Mass (kDa)
15N NMR Relaxation for WT (R2/R1=35.4) 3564( tc=18 ns at 310 K)
15N NMR Relaxation for F344A (R2/R1=18.8) 2063( tc=9.8 ns at 310 K)
SEC
1 for WT 3565 (at 277 K)
SEC
1 for F344A 2464 (at 277 K)
1H NMR gradient-echo
2 3565( D=9 610-11 m2/s at
310 K)
1Size-exclusion chromatography (SEC) using Superdex-75 HR/30 column
calibrated using molecular mass standards as described by [54].
2The lateral molecular diffusion coefficient (D) was measured using pulsed-field
gradient spin-echo NMR experiments as described by [55].
doi:10.1371/journal.pone.0023069.t002
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calculated as described in the Methods using both intermolecular
NOEs (Fig. 3) and residual dipolar couplings (Fig. S9). The
residues of A13DBD at the DNA interface were first experimen-
tally probed by NMR chemical shift mapping. Chemical shift
perturbations due to DNA binding [23] were observed for N-
terminal residues (R321, R324 and Y327) and residues in the C-
terminal helix (I366, N370, V373, K376 and K377). To identify
DNA contacts at atomic resolution, isotope-filtered NOESY
experiments (see Methods) were performed on NMR samples
that contained
13C-labeled A13DBD bound to unlabeled DNA
(Fig. 3). The NMR chemical shift assignments for A13DBD in the
complex [23] served as the basis for analyzing intermolecular
NOE signals from key residues at the protein-DNA interface
(Fig. 3). Intermolecular NOEs in the complex were assigned
mainly to protein residues (I368, N370 and V373) on the solvent-
exposed surface of the C-terminal helix.
The most striking intermolecular NOEs involve protein contacts
with pyrimidine methyl groups of thymine residues in the major
groove. The 11-mer DNA duplex in this study contains a total of 9
thymines. Each thymine methyl resonance was assigned by
generating a series of thymine-to-dexoyuridine (T-to-dU) mutants
(T5dU, T6*dU, T7*dU and T4*dU) in which the pyrimidine
methyl group for each thymine residue was replaced with a
hydrogen atom (see Fig. 1B for duplex base pair numbering).
Analysis of 2D
13C-filtered (F1 and F2) NOESY spectra that
specifically probed unlabeled DNA in these mutants (Fig. S8)
provided assignments for pyrimidine methyl groups and H6
resonances from all nine thymines, and H8 resonances in adjacent
adenines. The pyrimidine methyl resonances of T5, T6* and T7*
interact closely with both side-chain methyl groups of V373,
forming an intricate network of hydrophobic contacts (Fig. 3). The
T6* methyl is also close to the b-methylene group of N370. T3*
and T4* methyl groups interact closely with both methyl groups of
I366. Thus, the observed intermolecular NOEs (Fig. 3) represent
mostly hydrophobic interactions in the major groove and give rise
to a total of 38 intermolecular NOEs used in the structure
calculation described in the Methods.
The final NMR-derived structures of A13DBD bound to duplex
DNA are shown in Fig. 4 (RCSB Protein Databank accession no.
Figure 3. Slices from
1H-
1H planes of a 3D
13C-edited (F1) and
13C-filtered (F3) NOESY-HSQC spectrum recorded on
13C,
15N-labeled
A13DBD bound to unlabeled DNA. Representative two-dimensional planes are shown at different
13C chemical shifts and illustrate
intermolecular NOEs involving (A) I366 d1 methyl (F1:
13C=14.4 ppm), (B) I366 c2 methyl (F1:
13C=19.5 ppm), (C) N370 b methylene (F1:
13C=39.0
ppm), (D) V373 c1 methyl (F1:
13C=21.0 ppm), and (E) V373 c2 methyl (F1:
13C=23.0 ppm).
doi:10.1371/journal.pone.0023069.g003
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ensemble of structures consistent with the NMR data is shown in
Fig. 4A (RMSD =0.67 A ˚). The energy minimized average
structure is shown as a ribbon diagram in Fig. 4B. The N-
terminal arm region (residues 324–329) of A13DBD makes
important electrostatic contacts in the minor groove of DNA.
Positively charged protein residues K322 and K323 form
electrostatic contacts with backbone phosphate groups of T8*,
T10, and C11. The R324 side-chain forms hydrogen bonds with
the purine base of A8 and electrostatic contacts with the T6*
backbone. The phenolic group of Y327 forms a hydrogen-bond
with the backbone phosphate of A5*. The exposed residues of the
C-terminal helix (residues I366, N370 and V373) of A13DBD all
make important sequence-specific contacts in the major groove
(Fig. 4C). The side-chain of N370 forms contacts with the
pyrimidine methyl of T6* and hydrogen-bonding contacts with the
purine base of A5*: The side-chain carbonyl oxygen and amide
proton of N370 are hydrogen-bonded to the amine group and N7
atom of A5*, respectively. Also noteworthy are the network of
hydrophobic contacts between the side-chain methyl groups of
V373 and pyrimidine methyl groups of T5, T6* and T7*.
Additional hydrophobic contacts are formed by the side-chain
Figure 4. NMR-derived structures of A13DBD bound to 11-mer DNA duplex. (A) Ensemble of 10 lowest energy structures with RMSD of
0.67 A ˚ for A13DBD and 0.69 A ˚ for DNA. The helices are colored as defined in Fig. 2. (B) Ribbon diagram of energy-minimized average structure of
A13DBD/DNA complex. The C-terminal helix (green) of the protein contacts the major groove in duplex DNA, and the flexible N-terminal arm
interacts with the minor groove. (C) Close-up of the binding interface in the major groove. The key residues are shown as sticks (green) and wires
(yellow). The two methyl groups of V373 are close to the methyl groups of T5, T6* and T7* of DNA, the O atom in N370 side-chain is hydrogen-
bonded to the amino group of A5*, and the two methyl groups of I366 are close to the pyrimidine methyl groups of T3* and T4*.
doi:10.1371/journal.pone.0023069.g004
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T4*, and H8 atom of A5*. Positively charged residues (R371,
R372 and K381) at the end of the C-terminal helix form
electrostatic contacts with the backbone phosphate group of A4,
T7* and T8*.
Mutagenesis of DNA Binding Site
To experimentally verify the sequence-specific DNA contacts
suggested by our structure (Fig. 4C), the following protein mutants
(I366A, N370A, and V373G) were constructed and characterized
for DNA binding and transcriptional activity. All of the mutants
are stably folded (see DSC data in Fig. S3) and retain the same
NMR spectrum and structure as the wildtype protein (Fig. S4).
DNA binding to each of the mutants was monitored by ITC (Fig.
S7 and Table 4). The N370A mutant binds to DNA with ,1000-
fold lower affinity compared to wildtype, whereas I366A and
V373G each bind to DNA with 3-4-fold lower affinity. The
corresponding mutants in the full-length HOXA13 protein
showed reduced activity in transcriptional reporter assays. The
N370A mutant showed a complete loss of reporter activity,
whereas I366A and V373G showed a 40 and 58 percent reduction
in reporter activity respectively (Fig. S5). These results confirm
that I366, N370 and V373 all participate in DNA binding and
have important biological effects on transcription.
DNA Binding Affinity and Sequence Specificity
The V373G mutation was further analyzed for its affinity to
bind various DNA sequences. Fluorescence polarization anisotro-
py assays were use to calculate the Kd values of wt and V373G
A13DBD with different DNA sequences (Table 5). When
compared to wildtype A13DBD, V373G exhibited greater than
10-fold less affinity for all DNA sequences, suggesting that V373 in
A13DBD is important for DNA binding.
Sequence-specific DNA binding was examined by changing T5
and T6* nucleotides and comparing affinity for the different
binding sites with wt A13DBD. A thymine-to-deoxyuridine change
at T5 in the A13 binding site resulted in a 2-fold change in affinity,
however when changed to a cytosine the affinity decreased by
approximately 20-fold. Similarly a thymine-to-deoxyuridine and
thymine-to-cytosine change at T6* resulted in a 3-fold and 7-fold
change in affinity, respectively. This suggests that both the methyl
at position 5 and the oxygen at position 6 in T5 and T6* are
important for DNA sequence recognition by A13.
Competitive displacement experiments were performed to assess
the sequence specificity of DNA binding to wt and V373G
A13DBD (Fig. 5A). Labeled oligonucleotide was bound and
competed away from each protein by adding various amounts of a
corresponding non-labeled oligonucleotide (Fig. 5B). For all DNA
sequences, wt A13DBD was displaced more effectively when
compared to V373G, as expected from their large differences in
Kd. The relative specificity of the protein-DNA interaction for wt
versus V373G HOXA13 was inferred by comparing how much
scrambled oligonucleotide was needed to displace binding of the
consensus DNA sequence (Fig. 5C). Wt HOXA13 bound the
consensus DNA binding site strongly, and 1 mM or greater of
scrambled oligonucleotide was required to compete HOXA13
away. The V373G mutant protein bound much less tightly to the
consensus binding site and as little as 50 nM scrambled
oligonucleotide demonstrated the ability to compete for binding.
Protein Dimerization of A13DBD
The structure of the protein dimer in the (A13DBD)2-(DNA)2
complex could not be directly probed in our NMR experiments
due to spectral symmetry and an apparent lack of intermolecular
NOEs at the dimer interface, perhaps due to the dimerization off-
rate being faster than the NOE (T1) time scale. The NMR spectral
symmetry causes our experiments to view only half of the dimer
complex (i.e. one A13DBD molecule bound to one DNA duplex).
Therefore, we developed an alternative approach to infer the
structure of the protein interface by using a site-specific
Table 3. Structure Statistics for NMR-derived Structures of
A13DBD/DNA Complex.
Intermolecular NOEs 38
1DHN RDC 25
RDC Q-factor 0.078
Ramachandran plot: most favored region (%) 84.4
Ramachandran plot: allowed region (%) 14.1
Ramachandran plot: disallowed region (%) 1.5
RMSD (A ˚): Protein backbone atoms 0.67
RMSD (A ˚): DNA heavy atoms 0.69
RMSD (A ˚): Protein backbone + DNA heavy atoms 0.68
doi:10.1371/journal.pone.0023069.t003
Table 4. ITC parameters for DNA binding by A13DBD and mutants.
A13DBD WT WT WT WT I366A N370A V373A V373G V373G V373G
DNA WT T5U T5C T5UT6*U WT WT WT WT T5U T5C
Kd (nM) 7.5 14.5 285.7 40.3 43.7 862.1 18.7 137.2 236.0 617.3
DH(kcal/mol) -30.1 -24.3 -38.3 -23.3 -21.8 -0.01 -23.0 -1.6 -12.9 -25.1
T5U: T-to-dU DNA mutant (deoxythymine mutated to deoxyuridine).
T5C: T-to-C DNA mutant at 5 position of Strand 1 (Strand 1: 59-CAAACAAAATC-39, Strand 2: 59-GATTTTATTTG-39).
T5UT6*U: T-to-dU DNA mutant (deoxythymine mutated to deoxyuridine).
doi:10.1371/journal.pone.0023069.t004
Table 5. Kd values of A13DBD wt and V373G measured by
fluorescence depolarization.
DNA Sequence wt Kd (nM) V373G Kd (nM)
wt 2.1960.06 56.662.25
T5C 49.264.97 615.8656.1
T5U 4.0160.28 55.064.35
T6*C 5.9560.64 79.366.93
T6*U 16.462.07 200.4610.9
doi:10.1371/journal.pone.0023069.t005
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A13DBD bound to DNA reveals a relatively small exposed
surface (solvent exposed surface area =422 A ˚ 2) that would be
capable of forming a dimerization binding site. This exposed
surface contains a hydrophobic residue (F344) that very likely
might form a hydrophobic contact at the dimer interface. To test
this hypothesis, we made the mutant F344A that remains
structurally folded and does not affect DNA binding (Fig. S7).
Figure 5. Effects of site specific changes in the A13DBD DNA binding site and mutation of V373 on DNA binding affinity. Individual
mutations to the HOXA13 DNA binding site (Table S1) are depicted by each line or bar color. (A) Overlay plots show binding of wt A13DBD (left
panel) or V373G A13DBD (right panel) to various DNA mutants. (B) Competitive displacement assays, for wt (left panel) and V373G (right panel).
Wedges indicate an increasing amount of competitor DNA at concentrations of 0, 0.05, 0.1, 0.5, 1, 2.5, and 5 mM. (C) Displacement of the high affinity
consensus sequence by a scrambled oligonucleotide on wt (white bars) vs. V373G (gray bars). Wedges indicate an increasing amount of srcambled
competitor DNA at concentrations of 0, 0.05, 0.1, 0.5, 1, 2.5, and 5 mM. All data represent the average of three independent measurements for each
protein and oligonucleotide concentration. Error bars represent the standard deviation of the three independent experiments.
doi:10.1371/journal.pone.0023069.g005
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dimerization binding interaction as evidenced by SEC/MALS
data, indicating an apparent molar mass of 2564 kDa for the
F344A complex compared to 3565 kDa for that of wildtype (Fig.
S6). This result indicates that the F344A mutation weakens the
protein dimerization affinity (by at least 10-fold), consistent with
F344 being located in the dimerization binding site. We next
surveyed the available crystal structures of homedomains and
found that PDX1 forms a homodimer [15]. Interestingly, the
dimerization site on PDX1 contains an exposed tyrosine
(corresponding to F344 in HOXA13) that interacts closely with
a conserved arginine (corresponding to R337 in HOXA13). This
pair of residues was then mutated in A13DBD (R337A/F344A)
and tested for their effect on protein dimerization. The double
mutant does not affect DNA binding, but shows a pronounced
weakening of the dimerization affinity compared to that of F344A
(Fig. S6). Lastly, an exposed lysine (K343) next to F344 was
mutated (K343E), and this charge reversing mutation remained
structurally intact but lowered the dimerization affinity by ,5-
fold. In short, exposed residues (R337, K343 and F344) all
contribute to the dimerization binding energy and must be located
at the dimerization binding site.
These dimerization site residues (R337, K343 and F344) were
then used as unambiguous restraints to calculate the structure of
the dimer using HADDOCK (see methods). The calculated
structure of the dimer is very similar to the structure of a protein
dimer predicted by homology modeling based on the PDX1
crystal structure [15]. The structural model of the A13DBD dimer
is shown in Fig. 6A. In this dimeric structural arrangement, the
two duplex DNA molecules are bound at opposite ends of the
dimer (Fig. 6B). The structure of the A13DBD dimer therefore has
two exposed DNA binding sites that we suggest may bind to
multiple sites on the same DNA duplex or perhaps bind to two
separate DNA strands.
Functional Role of A13DBD Dimerization
Recognizing that the (A13DBD)2-(DNA)2 complex was highly
stable during its purification and NMR analysis, we hypothesized
that protein dimerization in this complex must exist under
physiological conditions and may be required to regulate target
gene expression. To test the functional role of protein dimeriza-
tion, wild type HOXA13 protein and mutant HOXA13 protein
bearing a substitution at the F344 dimerization site (F344A) were
evaluated for their capacity to regulate gene expression from the
EphA7 enhancer element that we previously identified to be
regulated by HOXA13 in vitro and was bound by full length
HOXA13 in embryonic tissues [22]. Analysis of normalized
luciferase expression confirmed that wt HOXA13 regulates gene
expression through the EphA7 cis-regulatory DNA element
(Figure 7). In contrast, substitution of the dimer-forming
phenylalanine residue with alanine at the position 344 generated
a mutant (F344A) that consistently reduced luciferase expression
from the same EphA7 cis-regulatory element by greater than
seventy five percent, confirming the importance of dimerization
and F344 in target gene regulation (Figure 7).
Discussion
In this study, we present the NMR structure of the A13DBD
dimer bound to duplex DNA (Fig. 4) and establish that HOXA13
dimerization is functionally important for activating transcription
(Fig. 7). The A13DBD dimer binds symmetrically to two separate
DNA duplex molecules at both ends of the dimer (Fig. 6B). At
each DNA binding site, the N-terminal arm of A13DBD (residues
324–329) makes electrostatic contacts in the DNA minor groove
(Fig. 4B), and a mutation in this region (R326G) is implicated in
Figure 6. A13DBD protein dimerization. (A) Main chain structure
of A13DBD dimer calculated by HADDOCK. Key residues at the dimer
interface (R337, K343 and F344) are highlighted. Mutating R337, K343,
and/or F344 dramatically weakens the dimerization affinity. (B)
Structure A13DBD dimer bound to two DNA duplex molecules.
doi:10.1371/journal.pone.0023069.g006
Figure 7. Luciferase assay in NG108-15 cells using a HOXA13
wt and F344A mutant. Percent luciferase activities (relative to wt
control) are indicated on the y axis. HOXA13 wt or F344A (normalized to
renilla and empty vector controls) are plotted on the x axis. Results are
the mean percent values calculated from three independent experi-
ments. Error bars represent the standard deviation of the three
independent experiments.
doi:10.1371/journal.pone.0023069.g007
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terminal helix (I366, N370 and V373) makes sequence specific
contacts in the major groove (Fig. 4C), and mutations in the C-
terminal helix are linked to HFGS [3]. The N-terminal arm and
last four residues of the C-terminal helix are structurally
disordered in the absence of DNA (Fig. 2A). These disordered
residues adopt a rigid structure upon binding to DNA (Fig. 4A).
We suggest the dynamic disorder at the N- and C-termini may
facilitate an induced-fit mechanism of DNA target recognition to
help explain the very high DNA binding affinity and sequence
specificity. Another distinctive structural feature of A13DBD (not
seen in other known homeodomains) is that exposed hydrophobic
residues (I366 and V373) form an extensive network of
hydrophobic contacts with thymine methyl groups in the major
groove. Particularly striking are the cooperative hydrophobic
contacts between V373 and the methyl groups of T5, T6* and T7*
that explain the highly specific recognition of 59-TAA-39 in the
major groove. In most other homeodomains, V373 is replaced
with methionine that specifically contacts cytosine (instead of
thymine) in the major groove as seen in the crystal structures of
HOXB1 [9] and other known homeodomains [15,16,17,19,25].
This valine substitution may explain in part why cytosine is NOT
present in the core DNA sequence for HOXA13 (59-AATAA-39
[8]).
HOXA13 belongs to the Group 13 subclass of the abdominal B
hox genes which in humans and mice contain four conserved
members (Hoxa13, Hoxb13, Hoxc13 and Hoxd13) that share about
90% sequence identity in their homeodomain regions. As a result,
their structures and DNA sequence recognition should all be
similar. Indeed, V373 (that is critical for sequence-specific DNA
binding) remains invariant in all members of this Group 13-
subfamily, but is not conserved in many other well known
homeodomain proteins like HOXB1 PDX1, ENGRAILED, and
HOXA9 (Fig. 1A). Our structure of A13DBD reveals that the two
side-chain methyl groups of V373 are responsible for the
recognition of 59-TAA-39 in the major groove due to the network
of hydrophobic contacts it makes with pyrimidine methyl groups
of T5, T6* and T7* (Fig. 4C). By contrast, a methionine
substituted in place of valine at this position in HOXB1 makes
very different contacts in the major groove [9]. We suggest that all
members of the Group 13-subfamily (HOXA13-D13) may
recognize a similar 59-TAA-39 sequence element, because they
all contain valine instead of methionine at this key position. The
Group 13-subclass is unique in having valine conserved at this
position, while all other homeodomains are known to have either
methionine or alanine. Previous analysis of the full-length
consensus HOXA13 binding site indicates that DNA affinity and
specificity may also be influenced by the nucleotides flanking the
59-TAA-39 core sequences, which could explain how each of the
Group 13 homeodomain proteins can regulate different develop-
mental processes even in the same tissues. Indeed, while HOXA13
and HOXD13, are strongly co-expressed in the limb during
development, their loss of function phenotypes are remarkably
different, suggesting that each protein must regulate a unique
cohort of genes in the developing limb [6,26,27].
Our structural analysis reveals that A13DBD forms a protein
dimer in solution (Fig. 6), which is functionally important for the
regulation of HOXA13 target gene expression (Figs. 7–8).
Mutations that weaken HOXA13 dimerization (F344A and
R337A/F344A) also diminish the amount of transcriptional
activation (Fig. 7). Hence, the HOXA13 dimerization suggests a
mechanism to explain how HOXA13 can both activate and
repress target gene expression [28]. We propose that the
HOXA13 dimer can form multivalent contacts with two separate
sites on the same DNA strand (Fig. 8A). The dimerization of
HOXA13 in this context would cause a bending of duplex DNA
(Fig. 8A), which has been previously shown to affect transcription
[29]. Alternatively, the HOXA13 dimerization might connect two
separate DNA duplexes (Fig. 8B) and thus simultaneously activate
transcription at both sites. Conditions that induce dimerization of
HOXA13 (e.g. absence of a repressor molecule or high
concentration of HOXA13) are expected to activate transcription
(Fig. 8, right panel). Conversely, conditions that promote
dissociation of the HOXA13 dimer (e.g. binding to a repressor
protein) are predicted to inhibit transcription (Fig. 8, left panel).
The HOXA13 dimerization may also have a role in explaining
possible disease phenotypes linked to polyalanine expansion
mutants [30,31,32]. Wild-type HOXA13 and HOXD13 have
been suggested to be mislocalized when coexpressed with mutant
HOXA13 that contains polyalanine expansions in vitro [32]. The
presence of additional alanine residues in the polyalanine tracts of
HOXA13 have been suggested to cause protein aggregation [33].
If the polyalanine mutant of HOXA13 forms a dimer with
wildtype HOXD13, then this heterodimerization might sequester
HOXD13 in the cytoplasm, which could result in lower levels of
normal HOXD13 in the nucleus and cause disease [34]. However,
studies on transgenic mice suggest that HOXA13 polyalanine tract
mutants are rapidly degraded in the cytosol and may not
colocalize with HOXD13 [30]. More rigorous biophysical analysis
and co-localization studies are needed to directly probe a binding
interaction between HOXA13 and HOXD13, and characterize
any consequent sequestration by polyalanine tract mutants.
The R337A/F344A dimerization sites in HOXA13 might also
interact with co-factor proteins. Indeed co-factors such as MEIS-
and PBC-class proteins have been shown to interact with HOX
proteins, which promote DNA binding and regulate target gene
expression [10,11,12,13,35]. However, the typical interaction
motifs for the PBC-class co-factors are not apparent in HOXA13
[35,36]. It is conceivable that a cofactor protein might interact
with F344 and/or R337 at the dimerization site, which could
modulate the dimerization equilibrium of HOXA13 and/or help
recruit transcriptional machinery needed to regulate target gene
expression (Fig. 8, left). An important next step will be to probe the
interaction of cofactor proteins with the exposed residues at the
dimerization site (Fig. 6).
An important distinguishing feature of HOXA13 is its capacity
to bind and bend DNA in the absence of any co-factors. We
suggest that homodimerization of HOXA13 by itself may be
sufficient to regulate target gene expression. This self-sufficient
activation by HOXA13 should effectively increase the number of
tissues where HOXA13 can regulate target gene expression and
could explain why HOXA13 controls so many specific develop-
mental processes. A key question moving forward is to determine
what cellular conditions will promote and/or affect the HOXA13
dimerization. One possibility is that a repressor protein may
compete for binding at the HOXA13 dimerization site and
prevent dimerization as depicted in Fig. 8. Also, the dimerization
equilibrium might be highly reversible and controlled thermody-
namically by mass action or other changes in the cell. Future
studies are needed to identify specific binding partner proteins and
understand how the regulatory domain in HOXA13 might be
involved in modulating dimerization to control gene expression.
Materials and Methods
HOXA13 reference sequence
Amino acid sequence numbering was defined using the Mus
musculus HOXA13 protein sequence from GenBank Accession
number:AAB03322.1 (NCBI) (see Fig. 1).
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HOXA13 DNA-binding domain (G320-S386) was subcloned
into the XhoI and BamHI restriction sites in the pET-15b
expression vector to make pHisA13DBD plasmid. All site-
directed mutation constructs were generated by using the
QuikChange mutagenesis kit (Stratagene), and the presence of
these mutations was confirmed by DNA sequencing. The
plasmids were transformed into BL21(DE3) competent cells for
protein over-expression. Un-labeled proteins were over-ex-
pressed in LB medium, and purified by following the standard
His-tag protein purification protocol. The pure His-tagged
proteins were cleaved by thrombin to remove His-tag, and then
purified by size-exclusion chromatography (Superdex-75). Uni-
formly
15N-labeled and
13C/
15N-labeled were over-expressed in
M9 with
15NHCl and
15NH4Cl/
13C-glucose by using high-yield
protein expression protocol [37], and purified as described
previously [14]. The identity and integrity of the final protein
sample was confirmed by SDS-PAGE.
Preparation of ProteinNDNA Complex
Single-stranded oligonucleotides (59-CAAATAAAATC-39 and 59-
GATTTTATTTG-39) and T-to-dU mutant oligonucleotides with
Figure 8. Schematic models of transcriptional regulation by HOXA13. HOXA13 (colored light blue) represses transcription when it is
monomeric (left) and activates transcription when it forms a homodimer (right). The HOXA13 homodimer can bind to two DNA sites (ATAA) within
the same DNA strand (A) or on two separate DNA molecules (B). The HOXA13 homodimerization activates transcription by bending the DNA that may
help to recruit the transcriptional machinery necessary to activate gene expression. Monomeric HOXA13 inhibits transcription (left) under conditions
that promote dimer dissociation (e.g. binding to a repressor molecule that blocks the dimerization site marked by R337 and F344).
doi:10.1371/journal.pone.0023069.g008
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Inc. For DNA duplex preparation, two single stranded DNA
oligonucleotides in annealing buffer (10 mM Tris-HCl, 100 mM
NaCl, 0.1 mM EDTA, pH 7.0) were mixed in 1:1 molar ratio,
and heated to 95uC for 5 min, then cooled to room temperature
over the course of several hours. Concentrations were measured
and calculated by absorbance at 260 nm. To make proteinNDNA
complex, protein was mixed with duplex DNA at 1:1 molar
equivalent amount, and the mixture was incubated at 15uC for
one hour. Finally the protein-DNA complex was purified by gel
filtration chromatography (Superdex-75) to remove any unbound
DNA.
Molecular Mass Analysis
Size exclusion chromatography (SEC) was performed on a
Superdex 75 HR 10/30 column (GE Healthcare) at 4uC. A 0.1 ml
aliquot of protein was loaded onto the column and eluted at a flow
rate of 0.5 ml/min. Molecular masses were analyzed by analytical
SEC performed in-line with a multi-angle light-scattering (MALS)
miniDawn instrument with a 690-nm laser (Wyatt Technologies,
Inc.) coupled to refractive index instrument (Optilab Rex, Wyatt
Technologies, Inc.). The molar mass of chromatographed protein
was calculated from the observed light scattering intensity and
differential refractive index [38] using ASTRA software (Wyatt
Technologies, Inc.) based on Zimm plot analysis using a refractive
index increment, dn/dc=0.185 L g
-1 [39]. Apparent molecular
weights were also calculated using a standard curve of Ve/Vo
versus the log of the molecular weights of standard proteins: b-
amylase (200 kDa), alcohol dehydrogenase (150 kDa), transferrin
(81 kDa), carbonic anhydrase (29 kDa), and myoglobin (17 kDa).
Vo is a void volume obtained using blue dextrane (2000 kDa) and
Ve is the elution volume.
NMR Spectroscopy
A13DBD (unlabeled,
15N- or
15N/
13C-labeled) was exchanged
into NMR buffer (20 mM NaPO4, 10%D2O, pH 7.0) and
concentrated to about 200–700 mM. For A13DBDNDNA complex,
the combined fractions from gel filtration chromatography
(Superdex-75) containing pure A13DBDNDNA was exchanged to
NMR buffer (20 mM NaPO4, 5 mM MgCl2, 10%D2O, pH 6.0)
and concentrated to about 0.5 mM. All NMR experiments were
performed at 285K for A13DBD samples and at 310K for
A13DBDNDNA complex samples, on Bruker Avance III 600 or
800 MHz spectrometers equipped with a four-channel interface
and triple-resonance cryoprobe (TCI) with pulse field gradients.
The
15N-
1H HSQC spectra were recorded on a sample of
15N-
labeled free A13DBD and a sample of
15N-protein labeled
A13DBDNDNA complex. The 3D experiments for NMR reso-
nance assignments of free protein and protein/DNA complex were
described previously [14,23]. Stereospecific assignments of chiral
methyl groups of valine and leucine were obtained by analyzing
1H-
13C HSQC experiments performed on a sample that contained
10%
13C labeling of A13DBD [40]. NOE distance restraints for
the A13DBD structure calculation were obtained from the analysis
of 3D NOESY experiments including
15N-edited NOESY-HSQC
and
13C-edited NOESY-HSQC recorded at 800 MHz on
15N-
labeled A13DBD and
13C/
15N-labeled A13DBD samples. For
A13DBD/DNA complex, a
13C/
15N-labeled A13DBD bound to
unlabeled DNA was used to record 3D
13C-edited NOESY-
HSQC to probe all NOEs within the labeled protein. 3-D
13C/
15N-filtered-(F3) and
13C-edited (F1) HSQC-NOESY [41]
selectively probed intermolecular NOEs, and 2D
13C/
15N-double-
filtered NOESY selectively probed DNA intramolecular NOEs.
The NOE mixing time was 120 ms in all NOESY experiments.
NMR data were processed using NMRPipe [42] and analyzed
with SPARKY.
NMR Residual Dipolar Coupling Measurements
For the measurement of residual dipolar couplings (RDCs) of
A13DBD bound to duplex DNA, the filamentous bacteriophage
Pf1 (Asla Biotech Ltd, Latvia) was used as an orienting medium.
Pf1 (10 mg/ml) was added to the
15N-labeled A13DBD protein/
DNA complex sample at pH 6.0, to produce weak alignment of
the complex. The extent of alignment was checked by measuring
the splitting of the deuterium resonance from D2O( , 8 Hz). One-
bond HN RDCs were recorded using the in-phase/anti-phase
pulse sequence [43], with 512 complex t1 (
15N) points for both the
isotropic and anisotropic samples. The alignment tensor compo-
nents were calculated by the PALES program [44]. All NMR
spectra were processed and analyzed using NMRPipe package.
15N NMR Relaxation Measurements
15N R1, R2, and
15N-{
1H} NOE experiments were performed
on A13DBD at 285K and A13DBDNDNA at 310K using standard
pulse sequences described previously [45]. Longitudinal magneti-
zation decay was recorded using six different times: 0.00, 0.10,
0.25, 0.50, 1.00 and 2.00 s. The transverse magnetization decay
was recorded with eight different delays: 0.000, 0.008, 0.016,
0.024, 0.032, 0.048, 0.064 and 0.080 s. To check the sample
stability, the transverse magnetization decay at 0.016 s was verified
unchanged before and after each set of measurements of both
15N
R1 and R2 experiments.
15N-{
1H} NOE values were obtained by
recording two sets of spectra in the presence and absence of a 3 s
proton saturation period. The NOE experiments were repeated 3
times to calculate the average and standard deviation of the NOE
values. The overall rotational correlation time for backbone amide
motion was determined using the protocol described previously
[46].
Structure Calculation
Backbone and side-chain NMR resonances were assigned as
described previously [14,23]. Analysis of NOESY data determined
nearly 800 interproton distance relationships throughout the free
protein [47]. The NMR-derived distances and dihedral angles
then served as constraints (see Table 1) for calculating the three-
dimensional structure of free protein using distance geometry and
restrained molecular dynamics. Structure calculations were
performed using the YASAP protocol within X-PLOR [48,49],
as described previously [50]. A total of 778 interproton distance
constraints were obtained by analysis of
13C-edited and
15N-edited
NOESY-HSQC spectra (120 ms mixing time) of
13C/
15N-labeled
A13DBD. In addition to the NOE-derived distance constraints,
the following additional constraints were included in the structure
calculation: 86 dihedral angle constraints (w and y); 54 distance
constraints for 27 hydrogen bonds verified by identifying slowly
exchanging amide protons in hydrogen-deuterium exchange
experiments. Fifty independent structures were calculated, and
the 15 structures of lowest energy were selected. The average total
and experimental distance energy were 1658 6 19 and 125
kcalNmol
-1. The average root-mean-square (rms) deviation from an
idealized geometry for bonds and angles were 0.0089 A ˚ and 1.96u.
None of the distance and angle constraints were violated by more
than 0.4 A ˚ and 4u, respectively.
The NMR structure of A13DBD bound to an 11-mer DNA
duplex (Fig. 1B) was calculated on the basis of intermolecular
NOEs and residual dipolar couplings using Haddock 2.0 [51]
(http://haddock.chem.uu.nl/). The starting structure of the DNA
duplex (B-form) was generated using 3D-DART [52]. The B-form
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observing characteristic NOE patterns from the DNA in the
complex. The NMR-derived structure of free A13DBD deter-
mined above was used as an initial starting structure in the
HADDOCK calculation. A few additional dihedral angle
restraints (generated by TALOS) were also included to extend
the length of helix 3 (residues 376–381), as determined by
chemical shift index [23]. A total of 38 intermolecular NOE
distance restraints from filtered NOESY experiments, including 25
unambiguous restraints and 13 ambiguous restraints (mainly from
three residues in the N-terminal flexible loop, K322, R324 and
Y327), were included in the HADDOCK calculation as well as
conformational restraints for the DNA. The structure calculation
protocol consists of three stages: rigid-body docking, semi-flexible
simulated annealing, and refinement in explicit solvent as
described previously [53]. After rigid-body docking, 200 lowest-
energy structures were selected for semi-flexible refinement using
all the NMR experimental restraints above. The protein side
chains from residues that exhibit intermolecular NOEs with DNA
were allowed to move in the semi-flexible annealing stage, and the
N-terminal unstructured residues (G320 to T328) were set to
remain flexible during the refinement. DNA bases (A4–A8 and
T4*–T8*) were defined as active, and considered to be flexible
during the semi-flexible annealing. The structures were further
refined in an explicit solvent including all NMR derived restraints.
In order to add the HN-N residual dipolar couplings into the
structure refinement, the ensemble of 10 lowest energy structures
generated from the first simulated annealing were used to calculate
the axial and rhombic components of the alignment tensor (Da and
Dr) using the PALES program [44]. The HN-N RDCs (total 25
1DNH RDC values in the structurally rigid region) were introduced
in the semi-flexible annealing and water refinement stages as direct
restraints (using the SANI statement). Ten structures having the
lowest HADDOCK energy were selected and went through
another stage of refinement using all NMR experimental
restraints. The ensemble of 10 final structures was superimposed
with a root-mean-squared deviation of 0.67 A ˚ (A13DBD) and
0.69 A ˚ (DNA) (see Table 3 for structural statistics). A Ramachan-
dran analysis of the ensemble of structures (evaluated by Procheck)
revealed 84.4% of residues in the most favored regions, 14.1% in
additional allowed regions, 1.5% in generously allowed regions,
and 0% in disallowed regions. Thus, the NMR-derived structures
of A13DBD bound to 11-mer DNA show good convergence and
are well defined by the NMR restraints.
Luciferase Assays
NG108-15 cells (ATCC#HB-12317) were maintained in
DMEM media (Gibco) supplemented with 10% FBS (Atlanta
Biologicals), HAT (Invitrogen) and 1% penicillin/streptomycin.
Cells (1610
5) were seeded in 12-well plates and grown for 24 h at
37uC with 5% CO2. Transfections were performed using
FuGENE6 transfection reagent (Roche), 0.1 mg pRL-CMV
Renilla, and 0.25 mg pCAGGS-HOXA13 wild type or mutants,
along with 0.5 mg of a pGL4.23 plasmid (Promega) containing an
EphA7 cis-regtulatory element previously shown to be regulated by
HOXA13 [22]. Empty pGL4.23 and pCAGGs expression vectors
were used as controls. The Dual-Glo Luciferase Assay system
(Promega) was used to detect luciferase activity 24 h post-
transfection in OptiPlate-96F black plates using a Fusion
Microplate Analyzer (Perkin Elmer). Six replicates of each
transfection were performed and the transfection assay was
repeated a total of 3 separate times. Results were normalized for
transfection efficiency using a Renilla luciferase expression vector as
described by the manufacturer (Promega). Because the pGL4.23
vector also contains several HOXA13 binding sites, background
activation of the empty pGL4.23 by HOXA13 was also subtracted
from the final luciferase levels after Renilla normalization.
Fluorescence Anisotropy
Fluorescence polarization anisotropy was performed using a
Beacon 2000 fluorescence polarization anisometer (Invitrogen).
Self-annealing oligonucleotides were synthesized carrying a
fluorescein via a hexyl linker (6-carboxyfluorescein) at the 59 end
and purified by high pressure liquid chromatography (Integrated
DNA Technologies). Oligonucleotide sequences are presented in
Table S1. Oligonucleotides were resuspended as a 100 mM stock
in Tris-EDTA buffer, diluted to 10 mM in 20 mM Tris pH 7.5, 80
mM KCl, 10 mM MgCl2, 0.2 mM EDTA. The oligonucleotides
were then denatured at 95uC for 10 min, and annealed by cooling
to room temperature for 30 min. DNA binding affinity was
determined using a fixed concentration of DNA (1 nM) and
increasing concentrations of HOXA13 DNA binding domain
(A13DBD). Wild type A13DBD protein (0–512 nM) or V373G (0–
4.9 mM) were added to a solution containing 1 nM fluorescein-
labeled DNA in 20 mM Tris pH 7.5, 80 mM KCl, 10 mM
MgCl2, 0.2 mM EDTA, 1 mM dithiothreitol, and incubated at
15uC for 20 min. Measurements were collected at 15uC with a 10-
s delay. The dissociation constants were calculated as previously
described [8]. All results are based on three independent
measurements for each protein and oligonuleotide combination.
In the competitive displacement assays, increasing concentrations
(0–5 mM) of unlabeled competitor DNA was added to either 400
nM wt A13 or 4 mM V373G protein bound to 1 nM labeled DNA.
Measurements were collected at 15uC with a 10-s delay and 3
independent experiments were performed.
Supporting Information
Figure S1 NMR titration of DNA binding to A13DBD. (A)
1H
NMR spectra of duplex DNA with stepwise addition of A13DBD
(molar ratio indicated on the right side) in 20mM phosphate buffer
(pH 6.0) with 80mM KCl, 5mM MgCl2 and 10%D2O at 285K.
(B)
1H NMR spectrum of A13DBD/duplex DNA complex in
20mM phosphate buffer (pH 6.0) with 80mM KCl, 5mM MgCl2
and 10%D2O at 310K. Spectral assignments of DNA imino
resonances are shown.
(DOC)
Figure S2 Molar mass of A13DBD/DNA complex determined
by
15N-NMR relaxation data. Spin-lattice relaxation rate
constants (A) and spin-spin relaxation rate constants (B) are
plotted versus residue number. All data were determined at
600MHz
1H frequency and 310K. Error bars are given as the
standard deviation of three independent measurements.
(DOC)
Figure S3 Differential scanning calorimetry thermograms of
A13DBD and mutants (see Methods).
(DOC)
Figure S4 Overlay of two-dimensional
1H-
15N HSQC spectra of
A13DBD (black) and mutants I366 (blue), N370 (cyan) and V373
(red) at 285K.
(DOC)
Figure S5 Luciferase assays in NG108-15 cells using a series of
HOXA13 mutants. Percent luciferase activities (relative to wt
control) are indicated on the y axis, and the various pCAGGS-
HOXA13 mutants are plotted on the x axis. Values represent the
mean percent luciferase activity from three independent experi-
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independent experiments.
(DOC)
Figure S6 Size-exclusion chromatography profiles of A13DBD
and mutants (F344A (red) and F344A/R337G (blue)) in complex
with duplex DNA.
(DOC)
Figure S7 Isothermal calorimetric titration monitoring
A13DBD binding to 11-mer DNA duplex as described in the
text. Representative ITC data are shown for wildtype (A) and
N370A (B) A13DBD.
(DOC)
Figure S8 NMR spectral analysis and assignment of DNA
resonances. (A) The superposition of 2D
13C-filtered (F1 and F2)
NOESY spectrum of
13C/
15N-labeled A13DBD bound to
unlabeled duplex DNA (wildtype, black) and three T-to-dU
mutants, T5U (purple), T17U (red) and T19U (green), recorded in
99.9% D2O at pH 6.0. The
1H chemical shift of three pyrimidine
methyl groups (from T5, T17, T19) can be assigned unambigu-
ously as shown in the spectra based on T-to-dU mutants. (B)
Sequential NOE assignments from 2D
13C-filtered NOESY of
13C/
15N-labeled A13DBD bound to unlabeled duplex DNA,
recorded in 99.9% D2O, showing the sequential NOE connections
between methyl protons of Ti and H6 of Ti-1 from T19 to T21 and
T14 to T17.
(DOC)
Table S1 Oligonucleotide sequences used in fluorescence
anisotropy assays.
(DOC)
Movie S1
(WMV)
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